Related Experiment Video
Updated: Mar 9, 2026
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
3.0K
Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
Hyun Jung Lee1, Bo-Mi Kim1, Soojung Shin1
1Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea; Catholic Institute for Visual Science, Catholic University of Korea, College of Medicine, Seoul, Republic of Korea.
Clinical Immunology (Orlando, Fla.)
|January 9, 2017
Summary
Extracellular superoxide dismutase 3 (SOD3) significantly reduces allergic conjunctivitis symptoms in mice. This finding suggests SOD3 as a potential therapeutic target for Th2-driven eye inflammation.
Area of Science:
- Immunology
- Ophthalmology
- Biochemistry
Background:
- Allergic conjunctivitis is an inflammatory eye condition driven by Th2 immune responses.
- Extracellular superoxide dismutase 3 (SOD3) plays a role in immune regulation.
- The specific function of SOD3 in allergic conjunctivitis requires further investigation.
Purpose of the Study:
- To investigate the role of extracellular superoxide dismutase 3 (SOD3) in experimental allergic conjunctivitis (EAC).
- To evaluate the therapeutic potential of topical SOD3 application in a murine model of allergic eye inflammation.
Main Methods:
- Experimental allergic conjunctivitis (EAC) was induced in mice using ovalbumin challenge.
- SOD3 was administered topically to assess its impact on allergy indicators.
- Key markers of allergic inflammation, including IgE, eosinophil infiltration, and immune cell populations, were quantified.
Main Results:
- Topical SOD3 treatment significantly reduced clinical signs of allergic conjunctivitis.
- OVA-specific IgE production, IgG1/IgG2a ratio, and eosinophil infiltration were markedly decreased in SOD3-treated mice.
- SOD3 treatment led to reduced numbers of conjunctival dendritic cells and CD4+ T cells.
- Attenuated allergic inflammation was associated with suppressed Th2 cytokine responses and enhanced Treg cytokine production.
Conclusions:
- Extracellular superoxide dismutase 3 (SOD3) effectively ameliorates allergic conjunctivitis in a murine model.
- SOD3 influences immune cell infiltration and cytokine profiles, shifting the balance away from Th2-mediated inflammation.
- SOD3 represents a promising therapeutic target for Th2-driven allergic conjunctival diseases.
